Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid

被引:90
作者
Fiore, Francesca
Castella, Barbara
Nuschak, Barbara
Bertieri, Raffaello
Mariani, Sara
Bruno, Benedetto
Pantaleoni, Francesca
Foglietta, Myriam
Boccadoro, Mario
Massaia, Massimo
机构
[1] Univ Turin, Div Ematol, I-10126 Turin, Italy
[2] Osped San Giovanni Battista Torino, Lab Ematol Oncol, CeRMS, Turin, Italy
关键词
D O I
10.1182/blood-2006-09-044321
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
V gamma 9/V delta 2 (gamma delta) T cells play a major role in innate immunity against microbes, stressed, and tumor cells. They represent less than 5% of peripheral blood lymphocytes but can be activated and expanded in vitro by aminobisphosphonates (ABP)treated monocytes. The aim of this work was to determine whether ABP-treated dendritic. cells (DCs) can also activate - delta T cells and regulate immune responses mediated by conventional up T cells. Highly purified immature (IDC) and mature DC (mDC) were generated from peripheral blood monocytes of healthy donors and incubated with zoledronic acid (Zol) for 24 hours. Zoltreated iDC and mDC retained their immunostimulatory properties and induced the vigorous expansion of central memory and effector memoryy gamma delta T cells. gamma delta T cells displayed antitumor activity and appropriate cell surface antigens to target secondary lymphoid organs and exert costimulatory activity. Antigen-specific MHC-restricted immune responses, mediated by conventional alpha beta T cells, were improved by the concurrent gamma delta T-cell activation. In conclusion, large numbers of gamma delta T cells with effector and costimulatory activities are rapidly generated by Zol-treated iDC/mDC. This strategy is worthy of further investigation to improve adoptive cell therapy and vaccine interventions against tumors and infections.
引用
收藏
页码:921 / 927
页数:7
相关论文
共 28 条
[1]
Recommendations for zoledronic acid treatment of patients with bone metastases [J].
Berenson, JR .
ONCOLOGIST, 2005, 10 (01) :52-62
[2]
Professional antigen-presentation function by human γδ T cells [J].
Brandes, M ;
Willimann, K ;
Moser, B .
SCIENCE, 2005, 309 (5732) :264-268
[3]
Reciprocal activating interaction between dendritic cells and pamidronate-stimulated γδ T cells:: role of CD86 and inflammatory cytokines [J].
Conti, L ;
Casetti, R ;
Cardone, M ;
Varano, B ;
Martino, A ;
Belardelli, F ;
Poccia, F ;
Gessani, S .
JOURNAL OF IMMUNOLOGY, 2005, 174 (01) :252-260
[4]
Potentiation of antigen-stimulated Vγ9Vδ2 T cell cytokine production by immature dendritic cells (DC) and recpirocal effect on DC maturation [J].
Devilder, MC ;
Maillet, S ;
Bouyge-Moreau, I ;
Donnadieu, E ;
Bonneville, M ;
Scotet, E .
JOURNAL OF IMMUNOLOGY, 2006, 176 (03) :1386-1393
[5]
Induction of γδ T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo [J].
Dieli, F ;
Gebbia, N ;
Poccia, F ;
Caccamo, N ;
Montesano, C ;
Fulfaro, F ;
Arcara, C ;
Valerio, MR ;
Meraviglia, S ;
Di Sano, C ;
Sireci, G ;
Salemo, A .
BLOOD, 2003, 102 (06) :2310-2311
[6]
Differentiation of effector/memory Vδ2 T cells and migratory routes in lymph nodes or inflammatory sites [J].
Dieli, F ;
Poccia, F ;
Lipp, M ;
Sireci, G ;
Caccamo, N ;
Di Sano, C ;
Salerno, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (03) :391-397
[7]
Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235
[8]
Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes [J].
Dyall, J ;
Latouche, JB ;
Schnell, S ;
Sadelain, M .
BLOOD, 2001, 97 (01) :114-121
[9]
Differentiation of human γδ T cells towards distinct memory phenotypes [J].
Eberl, M ;
Engel, R ;
Beck, E ;
Jomaa, H .
CELLULAR IMMUNOLOGY, 2002, 218 (1-2) :1-6
[10]
Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells [J].
Fiore, F ;
Nuschak, B ;
Peola, S ;
Mariani, S ;
Muraro, M ;
Foglietta, M ;
Coscia, M ;
Bruno, B ;
Boccadoro, M ;
Massaia, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (04) :1155-1163